STARSIL
LIVE

Serial Number

97184483

Owner

Hemostat Manufacturing GmbH

Attorney

Bryan W. Bockhop

Filing Date

Dec 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

STARSIL Trademark

Serial Number: 97184483

STARSIL is a trademark filed by Hemostat Manufacturing GmbH on December 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Hemostat Manufacturing GmbH (3 trademarks)

Beckelmannsweg 10

Entity Type: 99

Trademark Details

Filing Date

December 22, 2021

Registration Date

Not Registered

Published for Opposition

August 29, 2023

Goods & Services

Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical implants comprising living tissues; pharmaceutical preparations, namely, haemostatic agents, blood clotting agents, and blood clotting powder for use in improving blood coagulation and supporting natural blood cascade; adhesive bandages with blood clotting properties; pharmaceutical preparations for the treatment of infectious diseases; haemostatic agents in the nature of medical and dental haemostatic powder for medical purposes; chemical hemostatic preparations, namely, blood clotting agents for use in improving blood coagulation and supporting natural blood cascade; chemical hemostatic preparations, namely, blood clotting powder for use in improving blood coagulation and supporting natural blood cascade; haemostatic agents, namely, haemostatic powders in the nature of medical and dental haemostatic powder for medical purposes

Surgical instruments and apparatus; medical instruments and apparatus for treating all kinds of bleedings; dental instruments and apparatus for treating all kind of dental bleedings; orthopedic device for treating bleeding during orthopedic procedures; medical devices for closing wounds, namely, surgical stitches; blood clotting surgical sponge; surgical implants comprising artificial material with a blood clotting coating; blood clotting coated surgical implants from artificial materials

Filing History

SOU TEAS EXTENSION RECEIVED
Apr 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2025 EXRA
SOU EXTENSION 4 GRANTED
Oct 24, 2025 EX4G
SOU EXTENSION 4 FILED
Oct 24, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2025 EXRA
SOU EXTENSION 3 GRANTED
Apr 17, 2025 EX3G
SOU EXTENSION 3 FILED
Apr 16, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 24, 2024 EX2G
SOU EXTENSION 2 FILED
Oct 24, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 24, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 24, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 24, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 25, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 26, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 26, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 26, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 3, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 3, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 3, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2021 NWOS
NEW APPLICATION ENTERED
Dec 25, 2021 NWAP